220 research outputs found
Chalcid parasitoid community associated with the invadingpest Dryocosmus kuriphilus in north-western Italy
Diagnosis of primary aldosteronism in the hypertension specialist centers in Italy: a national survey
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades
n/
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study
Rapid start of antiretroviral therapy (ART) pending genotypic resistance test (GRT) has been recently proposed, but the effectiveness of this strategy is still debated. The rate of virological success (VS), defined as HIV-RNA\u2009<\u200950 copies/ml, with and without GRT was compared in drug-na\uefve individuals enrolled in the Italian ARCA cohort who started ART between 2015 and 2018. 521 individuals started ART: 397 without GRT (pre-GRT group) and 124 following GRT (post-GRT group). Overall, 398 (76%) were males and 30 (6%) were diagnosed with AIDS. In the pre-GRT group, baseline CD4+\u2009cell counts were lower (p\u2009<\u20090.001), and viral load was higher (p\u2009<\u20090.001) than in the post-GRT group. The estimated probability of VS in pre-GRT versus post-GRT group was 72.54% (CI95 : 67.78-76.60) versus 66.94% (CI95 : 57.53-74.26) at Week 24 and 92.40% (CI95 : 89.26-94.62) versus 92.92% (CI95 : 86.35-96.33) at Week 48, respectively (p\u2009=\u20090.434). At Week 48, VS was less frequent among individuals with baseline CD4+\u2009cell counts <200 versus >500 (90.33% vs. 97.33%), log viral load <5.00 versus >5.70 log10 cps/ml (97.17% vs 78.16%; p\u2009<\u20090.001), and those treated with protease inhibitors or non-nucleoside reverse transcriptase inhibitors versus those treated with integrase strand transfer inhibitors (p\u2009<\u20090.001). The rate of VS does not seem to be affected by an early ART initiation pending GRT results, but it could be influenced by the composition of the ART regimen, as well as immuno-virological parameters
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms
Recombination is recognized as a primary force in human immunodeficiency virus type 1 (HIV-1) evolution, increasing viral diversity through reshuffling of genomic portions. The strand-switching activity of reverse transcriptase is required to complete HIV-1 replication and can occur randomly throughout the genome, leading to viral recombination. Some recombination hotspots have been identified and found to correlate with RNA structure or sequence features. The aim of this study was to evaluate the presence of recombination hotspots in the pol gene of HIV-1 and to assess their correlation with the underlying RNA structure. Analysis of the recombination pattern and breakpoint distribution in a group of unique recombinant forms (URFs) detected two recombination hotspots in the pol region. Two stable and conserved hairpins were consistently predicted corresponding to the identified hotspots using six different RNA-folding algorithms on the URF parental strains. These findings suggest that such hairpins may play a role in the higher recombination rates detected at these positions
GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin
Background: There is some controversy as to whether tirofiban or eptifibatide, two small anti-aggregating drugs (AAD), may reduce the incidence of composite ischemic events within one year in patients undergoing percutaneous coronary intervention (PCI) in the real clinical world. Methods: We compared consecutive patients on oral double AAD (with clopidogrel and aspirin) who underwent PCI (n=207) and patients who were on single AAD and received a second AAD, just prior to PCI, and either high-dose tirofiban or double-bolus eptifibatide (double AAD plus small molecules group, n=666). The primary end point (incidence of composite ischemic events within one year) included death, acute myocardial infarction, unstable angina, stent thrombosis or repeat PCI or coronary bypass surgery (related to the target vessel PCI failure) and was modelled by Cox's regression. Results: There were 89 composite ischemic events: 24 (11.6%) in double AAD alone and 65 (9.8%) in double AAD plus small molecules groups (log-rank test: p=0.36). Incidences by type of ischemic events were similar between the 2 groups. Based on 21 potential covariates fitted simultaneously, adjusted hazard ratios (HR and 95% confidence intervals) showed that age (HR 1.03, 1.01-1.06, p=0.01), diabetes (HR 1.68, 1.01-2.79, p=0.05) and intra aortic balloon pump (HR 5.12, 2.36-11.10, p=0.0001) were significant risk factors whereas thrombolysis by tenecteplase (HR 0.35, 0.13-0.98, p=0.05) and having had hypertension or anti-hypertensive treatment (HR 0.58, 0.36-0.93, p=0.03) were significant protectors for events. Whether small molecules were present provided a non significant additional benefit as compared to double AAD alone (HR 0.83, 0.51-1.36, p=0.46). Pre-PCI CK-MB were not useful to predict events (HR 1.01, 0.99-1.01, p=0.17). Conclusions: In clinical world patients undergoing PCI (rescue plus primary <13%) while on double AAD, based on clopidogrel plus aspirin, small molecules (tirofiban or eptifibatide) provided no additive long-term protection against the occurrence of composite ischemic events whereas thrombolysis by tenecteplase did. © Schiariti et al
Lancet commission on hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure
The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standards. This problem is enabled through weak or absent regulations that allow clearance of devices for commercial use without formal validation. In addition, new BP technologies have emerged (e.g. cuffless sensors) for which there is no scientific consensus regarding BP measurement accuracy standards. Altogether, these issues contribute to the widespread availability of clinic and home BP devices with limited or uncertain accuracy, leading to inappropriate hypertension diagnosis, management and drug treatment on a global scale. The most significant problems relating to the accuracy of BP devices can be resolved by the regulatory requirement for mandatory independent validation of BP devices according to the universally-accepted International Organisation for Standardization Standard. This is a primary recommendation for which there is an urgent international need. Other key recommendations are development of validation standards specifically for new BP technologies and online lists of accurate devices that are accessible to consumers and health professionals. Recommendations are aligned with WHO policies on medical devices and universal healthcare. Adherence to recommendations would increase the global availability of accurate BP devices and result in better diagnosis and treatment of hypertension, thus decreasing the worldwide burden from high BP
Sustainability of biorefinery systems. Evaluation of biofuel productions by means of emergy and LCA.
The present dissertation is focused on the feasibility and sustainability study of biorefinery systems, to be implemented by using bioresidues and biowaste produced by agriculture and food-processing industry. Such energy productions represent an opportunity for developing countries that have a large availability of biomass resources (e.g. African countries) and most of all they contribute to meet the need of replacing fossil fuels with alternative energy sources (i.e. biofuels).
To this end the present work has explored hypothetical biofuel productions in the African continent from a sustainability standpoint, by adopting two environmental accounting methods such as emergy and life cycle assessment. The joint adoption of these two methodologies has been fundamental in order to provide a whole and complementary picture about the sustainability of the systems under study.
First of all some methodological aspects have been clarified with regard to the application of emergy to the different generation of biofuels, providing helpful guidelines for researchers and not-specialists as well that want to deal with emergy evaluation of biofuels. At the same time an innovative way to represent graphically emergy results has been developed. This representation is based on the principle of polar coordinates and it shows simultaneously quantitative and qualitative aspects of emergy outcomes.
Biofuel production chains have been evaluated on the basis of the different feasible biowastes that can be used to implement biorefinery systems (i.e. sugar and nutrient rich feedstocks). According to an emergy perspective, feedstocks like cassava peels and manure from grazing cattle proved to be the most promising biowaste in terms of potential production of biofuels and fertilizers, respectively.
With regard to the transformation phase of biowaste into final sustainable products, LCA outcomes have shown that lignocellulosic-based feedstock (i.e. corn stover) generates higher environmental burdens against starch-based feedstock (i.e. cassava peels), because of the higher energy requirement for treating biomass to make cellulose and hemicellulose accessible for the subsequent enzymatic hydrolysis.
In order to diminish the impacts of the by-products in output from biorefineries, part of the research has regarded the evaluation of the synergy that can be established between industrial and ecological systems, evaluating the ecosystems services provided by the latter as alternative to conventional solutions for treating plant emissions and waste production. From a methodological viewpoint this part of the study has explored the possible support that emergy can provide to improve and interpret the so-called techno-ecological synergy framework (i.e. TES)
Risk stratification and prognostic assessment by gated Single Photon Emission Computed Tomography (SPECT) in patients with Left Bundle-Branch Block (LBBB).
- …